In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.
- Characterization of therapeutic antibodies
- what, why, and when
- Benefits of early use of PC approaches to understand your product
- Complexities of monoclonal (mAbs) and their characterization
- Approaches to characterization of mAb physico-chemical and structural attributes
- Functional characterization of mAbs
